Surmodics to Present at Jefferies Healthcare Conference
May 29 2019 - 8:30AM
Business Wire
Webcast is Live on Tuesday, June 4, at 10:30
a.m. (ET)
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical
device and in vitro diagnostic technologies to the healthcare
industry, today announced that Gary Maharaj, president and chief
executive officer, and Tim Arens, vice president of finance and
chief financial officer, will make a presentation to the investment
community at the Jefferies 2019 Healthcare Conference in New York
City on Tuesday, June 4, 2019, at 10:30 a.m. ET
(9:30 a.m. CT).
A live audio webcast of the presentation will be available by
going to the investor relations portion of the Company’s website at
https://surmodics.gcs-web.com and clicking on the webcast icon. The
webcast will be archived on the Company’s website for 90 days
following the live presentation.
About Surmodics, Inc.
Surmodics is the global leader in surface modification
technologies for intravascular medical devices and a leading
provider of chemical components for in vitro diagnostic (IVD)
immunoassay tests and microarrays. Surmodics is pursuing highly
differentiated whole-product solutions that are designed to address
unmet clinical needs for its medical device customers and
engineered to the most demanding requirements. This key growth
strategy leverages the combination of the Company’s expertise in
proprietary surface technologies, along with enhanced device
design, development and manufacturing capabilities. The Company
mission remains to improve the detection and treatment of disease.
Surmodics is headquartered in Eden Prairie, Minnesota. For more
information, visit www.surmodics.com. The content of Surmodics’
website is not part of this press release or part of any filings
that the company makes with the SEC.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190529005027/en/
Tim Arens952-500-7000ir@surmodics.com
SurModics (NASDAQ:SRDX)
Historical Stock Chart
From Mar 2024 to Apr 2024
SurModics (NASDAQ:SRDX)
Historical Stock Chart
From Apr 2023 to Apr 2024